OZM, NNA, ROSG, CASM, XHB, MMYT Are Seasonally Ripe To Go Down In the Next Five Weeks
May 24, 2017 / M2 PRESSWIRE / BUYINS.NET / www.buyins.net is monitoring the Seasonality of Och-Ziff Capital Management Group LLC (NYSE:OZM), Navios Maritime Acquisition Corporation (NYSE:NNA), Rosetta Genomics Ltd. (NASDAQ:ROSG), CAS Medical Systems Inc. (NASDAQ:CASM), SPDR S&P HMBLDRS IDX FND (NYSE:XHB), MakeMyTrip Limited (NASDAQ:MMYT) and each have a high seasonal probability to go Down in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. buyins.net is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at:
The following stocks are expected to go Down:
Symbol Company Expected Return Odds By The Following Date OZM Och-Ziff Capital Management Group LLC -8.78% 88.89% (8 of 9) Thursday, July 6th 2017 NNA Navios Maritime Acquisition Corporation -8.03% 85.71% (6 of 7) Thursday, July 6th 2017 ROSG Rosetta Genomics Ltd. -10.89% 88.89% (8 of 9) Thursday, July 6th 2017 CASM CAS Medical Systems Inc. -7.53% 88.89% (16 of 18) Friday, June 9th 2017 XHB SPDR S&P HMBLDRS IDX FND -7.36% 81.82% (9 of 11) Thursday, June 22nd 2017 MMYT MakeMyTrip Limited -5.31% 66.67% (4 of 6) Wednesday, May 31st 2017Och-Ziff Capital Management Group LLC (NYSE:OZM) - Och-Ziff Capital Management Group LLC is a publicly owned hedge fund sponsor. The firm provides investment advisory services for its clients. It primarily caters to institutional investors which include pension funds, fund-of-funds, foundations and endowments, corporations and other institutions, private banks and family offices. The firm invests in equity and alternative markets across the world. It employs quantitative and qualitative analysis to make its investments. For its multi-strategy portfolios, the firm employs strategies like convertible and derivative arbitrage, corporate credit, long/short equity special situations, buyout investments, merger arbitrage, private investments, and structured credit. It also invests in real estate and traditional real estate assets including multifamily, office, hotel and retail, loans, portfolio acquisitions, loan pools, operating companies, structured debt products, public securities, and non-traditional real estate assets including gaming, distressed land and residential, cell towers, parking, golf, debt and senior housing. For private equity investments, it considers investments in a variety of special situations that seek to realize value through strategic sales or initial public offerings. The firm typically invests in the energy investments. It prefers to invest in United States. It also manages a buyout fund, Och-Ziff Energy Fund. Och-Ziff Capital Management Group LLC was founded in 1994 and is based New York City with additional offices in Houston, Texas, London, United Kingdom, Hong Kong, Tokyo, Japan, Bangalore, India, Singapore, and Beijing, China..
Navios Maritime Acquisition Corporation (NYSE:NNA) - Navios Maritime Acquisition Corporation provides marine transportation services worldwide. It owns a fleet of crude oil, refined petroleum product, and chemical tankers. The company charters its vessels to oil companies, refiners, and large vessel operators under long, medium, and short term charters. As of April 4, 2017, its fleet consisted of a total of 36 double-hulled tanker vessels aggregating approximately 3.9 million deadweight tons, which included 8 VLCC tankers, 8 Long Range 1 product tankers, 18 Medium Range 2 product tankers, and 2 chemical tankers. The company was founded in 2008 and is based in Monaco..
Rosetta Genomics Ltd. (NASDAQ:ROSG) - Rosetta Genomics Ltd. operates as a genomic diagnostics company worldwide. The company s microRNA technologies based diagnostic tests include RosettaGX Cancer Origin for the identification of the primary site of metastatic cancer; mi-KIDNEY, a kidney tumor classification test for pathology samples; RosettaGX Reveal for the diagnosis of indeterminate thyroid fine-needle aspirate samples; and mi-LUNG diagnostic tests. It also provides UroVysion, a urine-based Fluorescence In Situ Hybridization (FISH) assay that is intended for use in conjunction with and not in lieu of current standard diagnostic procedures, as an aid for initial diagnosis of bladder carcinoma in patients with hematuria and subsequent monitoring for tumor recurrence in patients previously diagnosed with bladder cancer; and ERG/PTEN, which are FISH-based prognostic tests in prostate cancer. In addition, the company offers ALK/ROS1 that are FISH-based predictive tests indicated for patients who are diagnosed with late stage lung cancer; and PCR gene mutation analysis for bladder, lung, colon, and melanoma patients. The company provides its diagnostic solutions for oncologists, urologists, endocrinologists, cytopathologists, and other specialists to facilitate them in serving their patients. It has a license agreement with Max Planck Innovation GmbH for the rights to its proprietary microRNAs for diagnostics and research purposes. Rosetta Genomics Ltd. was founded in 2000 and is headquartered in Rehovot, Israel..
CAS Medical Systems Inc. (NASDAQ:CASM) - CAS Medical Systems, Inc., a medical technology company, develops, manufactures, and markets non-invasive patient monitoring products worldwide. The company provides FORE-SIGHT tissue oximeter monitors, sensors, and accessories, as well as offers FORE-SIGHT ELITE monitors; and traditional monitoring products, such as non-invasive blood pressure measurement technologies under the MAXNIBP and MAXIQ brand names, as well as provides monitor service and repair. It markets products through its own sales force, distributors, manufacturers representatives, and original equipment manufacturers, as well as through hospital, surgery center and outpatient facility, homecare, veterinary, and emergency medical distribution channels. CAS Medical Systems, Inc. was incorporated in 1984 and is headquartered in Branford, Connecticut..
SPDR S&P HMBLDRS IDX FND (NYSE:XHB) - ST SPDR HMBLDRS E.
MakeMyTrip Limited (NASDAQ:MMYT) - MakeMyTrip Limited, an online travel company, provides travel products and solutions in India and internationally. It operates through two segments, Air Ticketing, and Hotels and Packages. The company s services and products include air tickets, hotels, packages, rail tickets, bus tickets, car hire, and ancillary travel requirements, such as facilitating access to travel insurance and visa processing. It allows travelers to research, plan, book, and purchase a range of travel services and products through its Websites makemytrip.com, makemytrip.ae, makemytrip.com.sg, us.makemytrip.com, hoteltravel.com, and easytobook.com; and other technology-enhanced distribution channels, including call centers, travel stores, and travel agents network, as well as mobile service platform. As of March 31, 2016, the company had 16 company-owned travel stores and 49 franchisee-owned travel stores. It serves leisure travelers and small businesses. The company was founded in 2000 and is based in Gurgaon, India..
About BUYINS.NET
BUYINS.NET, http://www.buyins.net, monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market-maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:
REGULATORY & COMPLIANCE NEWS Friction Factor - Market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements" Naked Shorts (RegSho) - Tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO
INVESTMENTS & TRADING Earnings - Predicts probability, price move and length of move before and after all US stock earnings reports Seasonality - Predicts probability, price move and length of move based on exact time of year for all US stocks Group Correlation - Tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups SqueezeTrigger - Massive database that tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock. Valuation - Tracks all known valuation models and applies them. GATS - Tracks and quantifies known trading strategies by backtesting, optimizing and running genetic algorithms and neural networks to ascertain best trading strategies. PatternScan - Automates tracking of every technical pattern and predicts next move in stocks. Insider - Tracks insiders trading records and determines trading performance. Trades by higher-level insiders are generally more predictive than trades by lower level insiders Events - Tracks patterns directly correlated to specific events.
SqueezeTrigger is a registered trademark, Reg. No. 3,120,641
DISCLAIMER:
BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. [symbol] has not approved the statements made in this release. Please read our report and visit our web site, http://www.buyins.net, for complete risks and disclosures.
Contact: BUYINS.NET Thomas Ronk 800-715-9999 tom@buyins.net http://www.buyins.net